Sharp drop in babies with RSV: new vaccine works excellently
The number of infants admitted to intensive care units with RSV has dropped significantly in the Netherlands following the introduction of a new, highly effective immunization program. Medical professionals report that the treatment, which provides immediate antibody protection, has eliminated the winter bed shortages previously caused by the virus.
The number of infants requiring intensive care due to the respiratory syncytial virus (RSV) has dropped significantly across the Netherlands this season, falling from 178 cases last year to 43. Pediatricians and public health officials attribute this sharp decline to the effectiveness of a new immunization program introduced in September 2025. Unlike traditional vaccines, this treatment provides infants with ready-made antibodies that offer immediate protection for the duration of the RSV season.
Health experts note that the program has seen high participation rates among parents, who are often well aware of the potential severity of the virus. Previously, hospitals frequently struggled to find available intensive care beds for critically ill infants during peak months, sometimes necessitating transfers as far away as Germany. Medical professionals now view the successful rollout of the immunization as a major milestone in pediatric care, as it prevents the dangerous breathing complications and intubation that often follow RSV infections in young babies.
Based on reporting by ad. Translated and condensed by LocalHeadlines.



